Chinese Online Healthcare Platform Joins $35M Series B Round Of Singaporean Start-Up

Biofourmis, a Singapore-based start-up that uses digital therapeutics for the treatment of chronic conditions, announced on Wednesday that it has closed US$35 million in a series B round of financing from investors including Chinese online healthcare platform Jianke.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

China Expert network

LEAVE A REPLY